Oncology and Hematology
17-32 of 152
- MinuteCE®
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
1.00 credit 10 episodes
A.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
- MinuteCE®
Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
1.00 program creditGiuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
Komal Jhaveri, MD, FACP
Giuseppe Curigliano, MD, PhD
Cynthia Villarreal-Garza, MD, DSc
Hiraji Iwata, MD, PhD
- MinuteCE®
Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
1.00 program creditKomal Jhaveri, MD, FACP
Giuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
Hiraji Iwata, MD, PhD
Giuseppe Curigliano, MD, PhD
- MinuteCE®
Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
1.00 program creditGiuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
Giuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
Cynthia Villarreal-Garza, MD, DSc
Kathleen Moore, MD, MS
Joyce F. Liu, MD, MPH
Kathleen Moore, MD, MS
Joyce F. Liu, MD, MPH
Kathleen Moore, MD, MS
- MinuteCE®
Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
0.50 program creditsJoyce F. Liu, MD, MPH
